×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
From Bedside to Bench to Bedside: How Adverse Events Converge Clinical Research and Clinical Care
Session Chair(s)
Allison Cuff Shimooka, MBA
Chief Operating Officer
TransCelerate Biopharma Inc, United States
This session explores adverse event collection, processing, and actioning fundamentals as critical for integrating patient safety within teams, organizations, and the broader clinical research and patient care ecosystems.
Learning Objective : Propose improvements within the drug safety landscape to adverse event reporting, processing, decision-making, and communication; Appraise stakeholder roles in protecting patients and promoting public health; Discuss opportunities for adverse event stakeholders to collaborate across the health care continuum (clinical development, safety, advocacy) to converge clinical research and clinical ca
Have an account?